These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17972908)

  • 21. Prevention of chronic kidney disease: the next step forward!
    de Jong PE; Gansevoort RT
    Nephrology (Carlton); 2006 Jun; 11(3):240-4. PubMed ID: 16756639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albuminuria: all you need to predict outcomes in chronic kidney disease?
    Gansevoort RT; Nauta FL; Bakker SJ
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):513-8. PubMed ID: 20802333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global burden of chronic kidney disease: how valid are the estimates?
    Glassock RJ; Winearls C
    Nephron Clin Pract; 2008; 110(1):c39-46; discussion c47. PubMed ID: 18689986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent progress in the management of CKD].
    Konta T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):17-20. PubMed ID: 22413574
    [No Abstract]   [Full Text] [Related]  

  • 27. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.
    Chang A; Kramer H
    Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease and chronic kidney disease: insights and an update.
    Best PJ; Reddan DN; Berger PB; Szczech LA; McCullough PA; Califf RM
    Am Heart J; 2004 Aug; 148(2):230-42. PubMed ID: 15308992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the new CKD-EPI equation to estimate the glomerular filtration rate].
    Montañés Bermúdez R; Bover Sanjuán J; Oliver Samper A; Ballarín Castán JA; Gràcia García S
    Nefrologia; 2010; 30(2):185-94. PubMed ID: 20038962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry.
    Gruberg L; Jeremias A; Rundback JH; Anderson HV; Spertus JA; Kennedy KF; Rosenfield KA
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):246-54. PubMed ID: 23813603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pros and cons of staging chronic kidney disease.
    Moseberry D; Nicholas SB
    Ethn Dis; 2010; 20(1):77-81. PubMed ID: 20178187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perspectives on the concept of CKD].
    Iseki K
    Nihon Jinzo Gakkai Shi; 2011; 53(1):15-7. PubMed ID: 21370572
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly.
    Wada M; Nagasawa H; Iseki C; Takahashi Y; Sato H; Arawaka S; Kawanami T; Kurita K; Daimon M; Kato T
    J Neurol Sci; 2008 Sep; 272(1-2):36-42. PubMed ID: 18541269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of glomerular filtration rate and of albuminuria/proteinuria.
    Cirillo M
    J Nephrol; 2010; 23(2):125-32. PubMed ID: 20213606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India.
    Varma PP; Raman DK; Ramakrishnan TS; Singh P; Varma A
    Nephrol Dial Transplant; 2010 Sep; 25(9):3011-7. PubMed ID: 20233739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.
    Bailie GR; Uhlig K; Levey AS
    Pharmacotherapy; 2005 Apr; 25(4):491-502. PubMed ID: 15977910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting and refining the staging of chronic kidney disease.
    Winearls CG; Glassock RJ
    Kidney Int; 2009 May; 75(10):1009-14. PubMed ID: 19242501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CKD surveillance: the next generation.
    Yee J
    Adv Chronic Kidney Dis; 2010 May; 17(3):211-2. PubMed ID: 20439088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.